Laxmisha Chandrashekar Selected Research

Laxmisha Chandrashekar Research Topics

Disease

16	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 02/2014
6	Inflammation (Inflammations) 05/2020 - 04/2016
5	Vitiligo 02/2021 - 06/2018
3	Pemphigus (Pemphigus Vulgaris) 01/2023 - 05/2017
3	Chronic Urticaria 04/2016 - 06/2013
2	Hypersensitivity (Allergy) 06/2023 - 07/2022
2	Contact Dermatitis (Eczema, Contact) 09/2022 - 07/2022
2	Alopecia (Baldness) 02/2022 - 11/2018
2	Alopecia Areata 02/2022 - 11/2018
1	Sclerotylosis 11/2023
1	Follicular Mucinosis 09/2023
1	Drug Eruptions (Drug Eruption) 06/2023
1	Herpes Simplex 01/2023
1	Infections 01/2023
1	Allergic Contact Dermatitis 09/2022
1	Atopic Dermatitis (Atopic Eczema) 09/2022
1	Skin Diseases (Skin Disease) 09/2022
1	Asthma (Bronchial Asthma) 07/2022
1	Insulin Resistance 03/2021
1	Tufted angioma 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Panniculitis 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Eosinophilic Fasciitis 01/2018
1	Esophageal Motility Disorders (Nutcracker Esophagus) 01/2018
1	Pyoderma Gangrenosum 05/2017
1	Neoplasms (Cancer) 02/2017
1	Hyperpigmentation 02/2017
1	Lentigo (Lentiginosis) 02/2017
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 02/2017
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2017
1	Lamellar Ichthyosis (Harlequin Ichthyosis) 01/2017
1	Pseudoainhum 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2016
1	Pleural Effusion (Pleural Effusions) 05/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 06/2023 - 10/2016
5	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 02/2014
5	C-Reactive ProteinIBA 11/2018 - 06/2015
3	InterleukinsIBA 06/2023 - 10/2015
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2015
3	Proteins (Proteins, Gene)FDA Link 07/2022 - 08/2016
3	Vitamin D FDA LinkGeneric 05/2020 - 06/2014
2	Irritants (Vesicants)IBA 09/2022 - 07/2022
2	SaltsIBA 02/2022 - 11/2018
2	AntioxidantsIBA 02/2021 - 08/2016
2	Malondialdehyde (Propanedial)IBA 02/2021 - 09/2015
2	Interleukin-10 (Interleukin 10)IBA 09/2020 - 02/2017
2	Antinuclear AntibodiesIBA 01/2018 - 01/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 06/2013
2	LipidsIBA 06/2017 - 09/2015
2	AntibodiesIBA 05/2017 - 09/2016
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2017 - 02/2014
2	Imatinib Mesylate (Gleevec)FDA Link 02/2017 - 08/2007
2	AcidsIBA 12/2015 - 03/2013
2	Interleukin-6 (Interleukin 6)IBA 10/2015 - 06/2015
2	P-SelectinIBA 06/2015 - 01/2014
1	Protein Isoforms (Isoforms)IBA 11/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 09/2023
1	Ointments (Pastes)IBA 09/2023
1	Interferon-gamma (Interferon, gamma)IBA 06/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2023
1	Immunoglobulin E (IgE)IBA 07/2022
1	LatexIBA 07/2022
1	AllergensIBA 07/2022
1	diphenylcyclopropenoneIBA 02/2022
1	Messenger RNA (mRNA)IBA 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 03/2021
1	Insulin (Novolin)FDA Link 03/2021
1	LeptinIBA 03/2021
1	AdiponectinIBA 03/2021
1	Aquaporins (Water Channels)IBA 02/2021
1	EnzymesIBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	SolutionsIBA 01/2021
1	Desmoglein 3IBA 01/2021
1	Timolol (Blocadren)FDA LinkGeneric 01/2021
1	Interleukin-13IBA 09/2020
1	Fumigant 93 (D-D)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	NLR ProteinsIBA 10/2019
1	Protein Tyrosine PhosphatasesIBA 06/2018
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2018
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 10/2017
1	Genetic Markers (Genetic Marker)IBA 08/2017
1	Cholinergic ReceptorsIBA 05/2017
1	Muscarinic AntagonistsIBA 05/2017
1	Interleukin-4 (Interleukin 4)IBA 02/2017
1	tazarotene (Tazorac)FDA Link 01/2017
1	oxidized low density lipoproteinIBA 09/2016
1	Lipoproteins (Lipoprotein)IBA 09/2016
1	Indicators and Reagents (Reagents)IBA 09/2016
1	Oxidants (Oxidizing Agents)IBA 08/2016
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 08/2016
1	Sialic AcidsIBA 08/2016
1	HLA-C Antigens (HLA-C)IBA 04/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2016

Therapy/Procedure

8	Therapeutics 08/2017 - 03/2013
1	Highly Active Antiretroviral Therapy (HAART) 05/2016